{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:14:05Z","timestamp":1792034045579,"version":"4.4.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23ck0106872 and JP24ck0106872"],"award-info":[{"award-number":["JP23ck0106872 and JP24ck0106872"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02941-z","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:20:14Z","timestamp":1758291614000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genetic and clinical characteristics of cranial nerve schwannoma harboring SH3PXD2A-HTRA1 fusion gene"],"prefix":"10.1007","volume":"150","author":[{"given":"Junki","family":"Sogano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Yo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ippei","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utaro","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azuna","family":"Tomioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Karatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"2941_CR1","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1097\/MAO.0000000000002580","volume":"41","author":"KA Aaron","year":"2020","unstructured":"Aaron KA, Manojlovic Z, Tu N, Xu Y, Jin Y, Chang S et al (2020) What genes can tell: a closer look at Vestibular Schwannoma. Otol Neurotol 41:522\u2013529. https:\/\/doi.org\/10.1097\/MAO.0000000000002580","journal-title":"Otol Neurotol"},{"key":"2941_CR2","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/ng.3688","volume":"48","author":"S Agnihotri","year":"2016","unstructured":"Agnihotri S, Jalali S, Wilson MR, Danesh A, Li M, Klironomos G et al (2016) The genomic landscape of schwannoma. Nat Genet 48:1339\u20131348. https:\/\/doi.org\/10.1038\/ng.3688","journal-title":"Nat Genet"},{"key":"2941_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00701-021-05072-y","volume":"164","author":"J Bal","year":"2022","unstructured":"Bal J, Bruneau M, Berhouma M, Cornelius JF, Cavallo LM, Daniel RT et al (2022) Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section part III: lower cranial nerve schwannomas, jugular foramen (CN IX, X, XI) and hypoglossal schwannoma (XII). Acta Neurochir (Wien) 164:321\u2013329. https:\/\/doi.org\/10.1007\/s00701-021-05072-y","journal-title":"Acta Neurochir (Wien)"},{"key":"2941_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00701-021-05048-y","volume":"164","author":"J Bal","year":"2022","unstructured":"Bal J, Bruneau M, Berhouma M, Cornelius JF, Cavallo LM, Daniel RT et al (2022) Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Part I: oculomotor and other rare non-vestibular schwannomas (I, II, III, IV, VI). Acta Neurochir (Wien) 164:285\u2013297. https:\/\/doi.org\/10.1007\/s00701-021-05048-y","journal-title":"Acta Neurochir (Wien)"},{"key":"2941_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00701-021-05092-8","volume":"164","author":"J Bal","year":"2022","unstructured":"Bal J, Bruneau M, Berhouma M, Cornelius JF, Cavallo LM, Daniel RT et al (2022) Management of non-vestibular schwannomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section Part II: trigeminal and facial nerve schwannomas (CN V, VII). Acta Neurochir (Wien) 164:299\u2013319. https:\/\/doi.org\/10.1007\/s00701-021-05092-8","journal-title":"Acta Neurochir (Wien)"},{"key":"2941_CR6","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1097\/MAO.0000000000001932","volume":"39","author":"ML Carlson","year":"2018","unstructured":"Carlson ML, Smadbeck JB, Link MJ, Klee EW, Vasmatzis G, Schimmenti LA (2018) Next generation sequencing of sporadic vestibular schwannoma: Necessity of biallelic NF2 inactivation and implications of accessory non-NF2 variants: Necessity of biallelic NF2 inactivation and implications of accessory non-NF2 variants. Otol Neurotol 39:e860\u2013e871. https:\/\/doi.org\/10.1097\/MAO.0000000000001932","journal-title":"Otol Neurotol"},{"key":"2941_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-05769-0","volume":"7","author":"H Chen","year":"2017","unstructured":"Chen H, Xue L, Wang H, Wang Z, Wu H (2017) Differential NF2 gene status in sporadic vestibular schwannomas and its prognostic impact on tumour growth patterns. Sci Rep 7:5470. https:\/\/doi.org\/10.1038\/s41598-017-05769-0","journal-title":"Sci Rep"},{"key":"2941_CR8","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.3171\/2014.2.jns131497","volume":"120","author":"Z Chen","year":"2014","unstructured":"Chen Z, Prasad SC, Di Lella F, Medina M, Piccirillo E, Taibah A et al (2014) The behavior of residual tumors and facial nerve outcomes after incomplete excision of vestibular schwannomas: clinical article. J Neurosurg 120:1278\u20131287. https:\/\/doi.org\/10.3171\/2014.2.jns131497","journal-title":"J Neurosurg"},{"key":"2941_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.2174\/156800909788486704","volume":"9","author":"J Chien","year":"2009","unstructured":"Chien J, Campioni M, Shridhar V, Baldi A (2009) HtrA serine proteases as potential therapeutic targets in cancer. Curr Cancer Drug Targets 9:451\u2013468. https:\/\/doi.org\/10.2174\/156800909788486704","journal-title":"Curr Cancer Drug Targets"},{"key":"2941_CR10","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1126\/science.1233009","volume":"339","author":"VE Clark","year":"2013","unstructured":"Clark VE, Erson-Omay EZ, Serin A, Yin J, Cotney J, Ozduman K et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339:1077\u20131080. https:\/\/doi.org\/10.1126\/science.1233009","journal-title":"Science"},{"key":"2941_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/his.14731","volume":"81","author":"K Collins","year":"2022","unstructured":"Collins K, Hwang M, Antic T, Paintal A, Argani P, Matoso A et al (2022) Merlin immunohistochemistry is useful in diagnosis of tumours within the spectrum of biphasic hyalinizing psammomatous renal cell carcinoma. Histopathology 81:577\u2013586. https:\/\/doi.org\/10.1111\/his.14731","journal-title":"Histopathology"},{"key":"2941_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10143-010-0289-y","volume":"34","author":"R Fukaya","year":"2010","unstructured":"Fukaya R, Yoshida K, Ohira T, Kawase T (2010) Trigeminal schwannomas: experience with 57 cases and a review of the literature. Neurosurg Rev 34:159\u2013171. https:\/\/doi.org\/10.1007\/s10143-010-0289-y","journal-title":"Neurosurg Rev"},{"key":"2941_CR13","doi-asserted-by":"publisher","DOI":"10.1177\/10935266241308946","author":"A Glembocki","year":"2024","unstructured":"Glembocki A, Siddaway R, Arnoldo A, Jakeman M, Lafreniere A (2024) Clinical and pathological features of a schwannoma harboring a SH3PXD2A::HTRA1 gene fusion in a pre-pubescent patient. Pediatr Dev Pathol. https:\/\/doi.org\/10.1177\/10935266241308946","journal-title":"Pediatr Dev Pathol"},{"key":"2941_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/neuonc\/noz153","volume":"22","author":"R Goldbrunner","year":"2020","unstructured":"Goldbrunner R, Weller M, Regis J, Lund-Johansen M, Stavrinou P, Reuss D et al (2020) EANO guideline on the diagnosis and treatment of vestibular schwannoma. Neuro Oncol 22:31\u201345. https:\/\/doi.org\/10.1093\/neuonc\/noz153","journal-title":"Neuro Oncol"},{"key":"2941_CR15","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1093\/neuonc\/noad078","volume":"25","author":"EC Hardin","year":"2023","unstructured":"Hardin EC, Schmid S, Sommerkamp A, Bodden C, Heipertz A-E, Sievers P et al (2023) LOGGIC Core BioClinical Data Bank: added clinical value of RNA-Seq in an international molecular diagnostic registry for pediatric low-grade glioma patients. Neuro Oncol 25:2087\u20132097. https:\/\/doi.org\/10.1093\/neuonc\/noad078","journal-title":"Neuro Oncol"},{"key":"2941_CR16","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/lary.25779","volume":"126","author":"JT Jacob","year":"2016","unstructured":"Jacob JT, Carlson ML, Driscoll CL, Link MJ (2016) Volumetric analysis of tumor control following subtotal and near-total resection of vestibular schwannoma: recurrence following partial VS resection. Laryngoscope 126:1877\u20131882. https:\/\/doi.org\/10.1002\/lary.25779","journal-title":"Laryngoscope"},{"key":"2941_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01423-7","volume":"10","author":"MA Karajannis","year":"2022","unstructured":"Karajannis MA, Li BK, Souweidane MM, Liechty B, Yao J, Benhamida JK et al (2022) YAP1-MAML2 fusion in a pediatric NF2-wildtype intraparenchymal brainstem schwannoma. Acta Neuropathol Commun 10:117. https:\/\/doi.org\/10.1186\/s40478-022-01423-7","journal-title":"Acta Neuropathol Commun"},{"key":"2941_CR18","doi-asserted-by":"publisher","first-page":"4260","DOI":"10.1038\/s41388-018-0258-4","volume":"37","author":"R Klose","year":"2018","unstructured":"Klose R, Adam MG, Weis E-M, Moll I, W\u00fcstehube-Lausch J, Tetzlaff F et al (2018) Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis. Oncogene 37:4260\u20134272. https:\/\/doi.org\/10.1038\/s41388-018-0258-4","journal-title":"Oncogene"},{"key":"2941_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2024.100427","volume":"37","author":"J-C Lee","year":"2024","unstructured":"Lee J-C, Lee P-H, Li S-C, Liao K-C, Chang Y-M, Chen H-C et al (2024) Systematic characterization of the clinical and pathological features of schwannomas harboring SH3PXD2A::HTRA1 fusion. Mod Pathol 37:100427. https:\/\/doi.org\/10.1016\/j.modpat.2024.100427","journal-title":"Mod Pathol"},{"key":"2941_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-48655-w","volume":"15","author":"Y Li","year":"2024","unstructured":"Li Y, Wei Y, Ultsch M, Li W, Tang W, Tombling B et al (2024) Cystine-knot peptide inhibitors of HTRA1 bind to a cryptic pocket within the active site region. Nat Commun 15:4359. https:\/\/doi.org\/10.1038\/s41467-024-48655-w","journal-title":"Nat Commun"},{"key":"2941_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40408-5","volume":"15","author":"SJ Liu","year":"2024","unstructured":"Liu SJ, Casey-Clyde T, Cho NW, Swinderman J, Pekmezci M, Dougherty MC et al (2024) Epigenetic reprogramming shapes the cellular landscape of schwannoma. Nat Commun 15:476. https:\/\/doi.org\/10.1038\/s41467-023-40408-5","journal-title":"Nat Commun"},{"key":"2941_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00401-020-02230-x","volume":"141","author":"S Mansouri","year":"2021","unstructured":"Mansouri S, Suppiah S, Mamatjan Y, Paganini I, Liu JC, Karimi S et al (2021) Epigenomic, genomic, and transcriptomic landscape of schwannomatosis. Acta Neuropathol 141:101\u2013116. https:\/\/doi.org\/10.1007\/s00401-020-02230-x","journal-title":"Acta Neuropathol"},{"key":"2941_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2022.100036","volume":"36","author":"SD Martin","year":"2023","unstructured":"Martin SD, Cheung S, Churg A (2023) Immunohistochemical demonstration of Merlin\/NF2 loss in mesothelioma. Mod Pathol 36:100036","journal-title":"Mod Pathol"},{"key":"2941_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s10014-023-00466-5","volume":"40","author":"N Ogasawara","year":"2023","unstructured":"Ogasawara N, Yamashita S, Yamasaki K, Kawano T, Kawano T, Muta J et al (2023) Spontaneous malignant transformation of trigeminal schwannoma: consideration of responsible gene alterations for tumorigenesis\u2014a case report. Brain Tumor Pathol 40:222\u2013229. https:\/\/doi.org\/10.1007\/s10014-023-00466-5","journal-title":"Brain Tumor Pathol"},{"key":"2941_CR25","doi-asserted-by":"publisher","DOI":"10.1227\/neu.0000000000003508","author":"K Ohara","year":"2025","unstructured":"Ohara K, Miyawaki S, Teranishi Y, Komura D, Mitsui J, Ikemura M et al (2025) Genetic analysis of intracranial schwannomas: differential NF2 alteration frequencies in nonvestibular schwannomas versus vestibular schwannomas. Neurosurgery. https:\/\/doi.org\/10.1227\/neu.0000000000003508","journal-title":"Neurosurgery"},{"key":"2941_CR26","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1126\/science.1164382","volume":"321","author":"DW Parsons","year":"2008","unstructured":"Parsons DW, Jones S, Zhang X, Lin JC-H, Leary RJ, Angenendt P et al (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807\u20131812. https:\/\/doi.org\/10.1126\/science.1164382","journal-title":"Science"},{"key":"2941_CR27","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/neuonc\/noad066","volume":"25","author":"SR Plotkin","year":"2023","unstructured":"Plotkin SR, Allen J, Dhall G, Campian JL, Clapp DW, Fisher MJ et al (2023) Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma. Neuro Oncol 25:1498\u20131506. https:\/\/doi.org\/10.1093\/neuonc\/noad066","journal-title":"Neuro Oncol"},{"key":"2941_CR28","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.gim.2022.05.007","volume":"24","author":"SR Plotkin","year":"2022","unstructured":"Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO et al (2022) Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: an international consensus recommendation. Genet Med 24:1967\u20131977. https:\/\/doi.org\/10.1016\/j.gim.2022.05.007","journal-title":"Genet Med"},{"key":"2941_CR29","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/MAO.0000000000002096","volume":"40","author":"DS Roberts","year":"2019","unstructured":"Roberts DS, Maurya R, Takemon Y, Vitte J, Gong L, Zhao J et al (2019) Linked-read sequencing analysis reveals tumor-specific genome variation landscapes in Neurofibromatosis type 2 (NF2) patients. Otol Neurotol 40:e150\u2013e159. https:\/\/doi.org\/10.1097\/MAO.0000000000002096","journal-title":"Otol Neurotol"},{"key":"2941_CR30","doi-asserted-by":"publisher","first-page":"176","DOI":"10.2176\/nmc.46.176","volume":"46","author":"HJ Seol","year":"2006","unstructured":"Seol HJ, Kim C-H, Park C-K, Kim CH, Kim DG, Chung Y-S et al (2006) Optimal extent of resection in vestibular schwannoma surgery: relationship to recurrence and facial nerve preservation. Neurol Med Chir (Tokyo) 46:176\u2013180. https:\/\/doi.org\/10.2176\/nmc.46.176. (discussion 180-1)","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2941_CR31","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.nec.2004.02.005","volume":"15","author":"DM Skovronsky","year":"2004","unstructured":"Skovronsky DM, Oberholtzer JC (2004) Pathologic classification of peripheral nerve tumors. Neurosurg Clin N Am 15:157\u2013166. https:\/\/doi.org\/10.1016\/j.nec.2004.02.005","journal-title":"Neurosurg Clin N Am"},{"key":"2941_CR32","doi-asserted-by":"publisher","first-page":"1099384","DOI":"10.3389\/fonc.2023.1099384","volume":"13","author":"K Takahara","year":"2023","unstructured":"Takahara K, Tamura R, Kuranari Y, Karatsu K, Akiyama T, Toda M (2023) Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in surgically resected schwannomas. Front Oncol 13:1099384. https:\/\/doi.org\/10.3389\/fonc.2023.1099384","journal-title":"Front Oncol"},{"key":"2941_CR33","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1200\/JCO.23.02376","volume":"42","author":"R Tamura","year":"2024","unstructured":"Tamura R, Yamanobe Y, Fujioka M, Morimoto Y, Fukumura M, Nakaya M et al (2024) Phase I\/II study of a vascular endothelial growth factor receptor vaccine in patients with NF2-related schwannomatosis. J Clin Oncol 42:2578\u20132587. https:\/\/doi.org\/10.1200\/JCO.23.02376","journal-title":"J Clin Oncol"},{"key":"2941_CR34","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2176\/jns-nmc.2024-0067","volume":"64","author":"R Tamura","year":"2024","unstructured":"Tamura R, Yo M, Toda M (2024) Historical development of diagnostic criteria for NF2-related schwannomatosis. Neurol Med Chir (Tokyo) 64:299\u2013308. https:\/\/doi.org\/10.2176\/jns-nmc.2024-0067","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"2941_CR35","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11060-021-03796-6","volume":"154","author":"P Taule-Sivertsen","year":"2021","unstructured":"Taule-Sivertsen P, Bruland O, H\u00e5vik AL, Bratland E, Lund-Johansen M, Knappskog PM (2021) The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. J Neurooncol 154:35\u201340. https:\/\/doi.org\/10.1007\/s11060-021-03796-6","journal-title":"J Neurooncol"},{"key":"2941_CR36","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/neuonc\/noad121","volume":"25","author":"EA Williams","year":"2023","unstructured":"Williams EA, Ravindranathan A, Gupta R, Stevers NO, Suwala AK, Hong C et al (2023) Novel SOX10 indel mutations drive schwannomas through impaired transactivation of myelination gene programs. Neuro Oncol 25:2221\u20132236. https:\/\/doi.org\/10.1093\/neuonc\/noad121","journal-title":"Neuro Oncol"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02941-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02941-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T14:20:15Z","timestamp":1758291615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02941-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2941"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02941-z","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]},"assertion":[{"value":"2 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This retrospective study integrated histopathological and molecular analyses. The study was approved by the Ethics Committee of Keio University School of Medicine. The molecular and clinical analyses were conducted under protocol number 20050002, and the whole-genome sequencing component was approved under protocol number 20221008. All the procedures were conducted in accordance with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent for the use of clinical data and research participation was obtained from all the patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"31"}}